Table of Contents
ISRN Dermatology
Volume 2012 (2012), Article ID 248951, 5 pages
http://dx.doi.org/10.5402/2012/248951
Clinical Study

Prevalence and Antibiotic Susceptibility of Community-Associated Methicillin-Resistant Staphylococcus aureus in a Rural Area of India: Is MRSA Replacing Methicillin-Susceptible Staphylococcus aureus in the Community?

1Department of Infectious Diseases, Rural Development Trust Hospital, Kadiri Road, Bathalapalli 515661, India
2Department of Microbiology, Rural Development Trust Hospital, Kadiri Road, Bathalapalli 515661, India

Received 31 August 2012; Accepted 24 September 2012

Academic Editors: F. Guarneri, F. Kaneko, E. Pasmatzi, and R. A. Schwartz

Copyright © 2012 Gerardo Alvarez-Uria and Raghuprakash Reddy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Popovich and B. Hota, “Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections,” Dermatologic Therapy, vol. 21, no. 3, pp. 167–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Z. David and R. S. Daum, “Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic,” Clinical Microbiology Reviews, vol. 23, no. 3, pp. 616–687, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Skinner and C. S. Keefer, “Significance of bacteremia caused by Staphylococcus aureus: a study of one hundred and twenty-two cases and a review of the literature concerned with experimental infection in animals,” Archives of Internal Medicine, vol. 68, p. 851, 1941. View at Google Scholar
  4. J. J. Plorde and J. C. Sherris, “Staphylococcal resistance to antibiotics: origin, measurement, and epidemiology,” Annals of the New York Academy of Sciences, vol. 236, pp. 413–434, 1974. View at Google Scholar · View at Scopus
  5. C. Griffiths, T. L. Lamagni, N. S. Crowcroft, G. Duckworth, and C. Rooney, “Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993–2002,” Health Statistics Quarterly, no. 21, pp. 15–22, 2004. View at Google Scholar · View at Scopus
  6. S. Stefani, D. R. Chung, J. A. Lindsay et al., “Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods,” International Journal of Antimicrobial Agents, vol. 39, pp. 273–282, 2012. View at Google Scholar
  7. R. Skov, K. Christiansen, S. J. Dancer et al., “Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA),” International Journal of Antimicrobial Agents, vol. 39, pp. 193–200, 2012. View at Google Scholar
  8. WHO. World Health Statistics, 2011.
  9. WHO. The evolving threat of antimicrobial resistance—options for action, 2012.
  10. K. Chua, F. Laurent, G. Coombs, M. L. Grayson, and B. P. Howden, “Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA—its evolving antimicrobial resistance and implications for therapy,” Clinical Infectious Diseases, vol. 52, no. 1, pp. 99–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. Global Antibiotic Resistance Partnership (GARP)—India Working Group, “Rationalizing antibiotic use to limit antibiotic resistance in India,” Indian Journal of Medical Research, vol. 134, pp. 281–294, 2011. View at Google Scholar
  12. G. Alvarez-Uria, U. Priyadarshini, P. K. Naik, M. Midde, and R. Reddy, “Mortality associated with community-acquired cephalosporin-resistant Escherichia coli in patients admitted to a district hospital in a resource-limited setting,” Clinics and Practice, vol. 2, article e76, 2012. View at Google Scholar
  13. Clinical and Laboratory Standards Institute, Performance Standard for Antimicrobial Disk Susceptibility Tests, 2009.
  14. T. P. Levin, B. Suh, P. Axelrod, A. L. Truant, and T. Fekete, “Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 3, pp. 1222–1224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Cauwelier, B. Gordts, P. Descheemaecker, and H. Van Landuyt, “Evaluation of a disk diffusion method with cefoxitin (30 μg) for detection of methicillin-resistant Staphylococcus aureus,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 23, no. 5, pp. 389–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Morrison, J. C. Hageman, and R. M. Klevens, “Case definition for community-associated methicillin-resistant Staphylococcus aureus,” Journal of Hospital Infection, vol. 62, no. 2, p. 241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. U. Nagaraju, G. Bhat, M. Kuruvila, G. S. Pai, A. Jayalakshmi, and R. P. Babu, “Methicillin-resistant Staphylococcus aureus in community-acquired pyoderma,” International Journal of Dermatology, vol. 43, no. 6, pp. 412–414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Thind, S. K. Prakash, A. Wadhwa, V. K. Garg, and B. Pati, “Bacteriological profile of community-acquired pyodermas with special reference to methicillin resistant Staphylococcus aureus,” Indian Journal of Dermatology, Venereology and Leprology, vol. 76, no. 5, pp. 572–574, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. H. Song, P. R. Hsueh, D. R. Chung et al., “Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 5, pp. 1061–1069, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Goud, S. Gupta, U. Neogi et al., “Community prevalence of methicillin and vancomycin resistant Staphylococcus aureus in and around Bangalore, southern India,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 44, no. 3, pp. 309–312, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. A. de Kraker, M. Wolkewitz, P. G. Davey et al., “Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 2, pp. 398–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. E. A. De Kraker, M. Wolkewitz, P. G. Davey et al., “Clinical impact of antimicrobial resistance in European Hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections,” Antimicrobial Agents and Chemotherapy, vol. 55, pp. 1598–1605, 2011. View at Google Scholar
  23. R. Horton and P. Das, “Indian health: the path from crisis to progress,” The Lancet, vol. 377, no. 9761, pp. 181–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Yamaguchi, I. Nakamura, K. Chiba, and T. Matsumoto, “Epidemiological and microbiological analysis of community-associated methicillin-resistant Staphylococcus aureus strains isolated from a Japanese hospital,” Japanese Journal of Infectious Diseases, vol. 65, pp. 175–178, 2012. View at Google Scholar
  25. G. I. Brennan, A. C. Shore, S. Corcoran, S. Tecklenborg, D. C. Coleman, and B. O’Connell, “Emergence of hospital- and community-associated panton-valentine leukocidin-positive methicillin-resistant Staphylococcus aureus genotype ST772-MRSA-V in Ireland and detailed investigation of an ST772-MRSA-V cluster in a neonatal intensive care unit,” Journal of Clinical Microbiology, vol. 50, pp. 841–847, 2012. View at Google Scholar
  26. C. Mandelia, S. Shenoy, and Y. Garg, “Antibiotic sensitivity pattern of community associated-methicillin resistant Staphylococcus aureus,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 45, p. 418, 2012. View at Google Scholar
  27. K. J. Popovich, R. A. Weinstein, and B. Hota, “Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?” Clinical Infectious Diseases, vol. 46, no. 6, pp. 787–794, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. P. L. Mehndiratta and P. Bhalla, “Typing of Methicillin resistant Staphylococcus aureus: a technical review,” Indian Journal of Medical Microbiology, vol. 30, pp. 16–23, 2012. View at Google Scholar
  29. N. D'Souza, C. Rodrigues, and A. Mehta, “Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India,” Journal of Clinical Microbiology, vol. 48, no. 5, pp. 1806–1811, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. Shambat, S. Nadig, S. B. Prabhakara, M. Bes, J. Etienne, and G. Arakere, “complexes and virulence factors of Staphylococcus aureus from several cities in India,” BMC microbiology, vol. 12, article 64, 2012. View at Google Scholar